Skip to main content

Table 2 Adverse events characteristics

From: Adverse event reporting in adult intensive care units and the impact of a multifaceted intervention on drug-related adverse events

Variable

First 12 months

Last 12 months

Whole study period

No. of AEs

1071

976

2047

Person reporting, n (%)

   

  Nurse

869 (81)

888 (91)

1757 (86)

  MD

190 (18)

79 (8)

269 (13)

  Other

12 (1)

9 (1)

21 (1)

Role of reporter, n (%)

   

  Eye-witnessed the AE

494 (46)

509 (52)

1003 (49)

  Involved in AE occurrence

395 (37)

321 (33)

716 (35)

  Was called for help

138 (13)

129 (13)

267 (13)

  Missing data

30 (3)

31 (3)

61 (3)

Patients NEMS in AEs questionnaire, n (%)

   

  NEMS ≥25

227 (21)

203 (21)

430 (21)

  NEMS 22-24

450 (42)

430 (44)

880 (43)

  NEMS 14-21

302 (28)

251 (26)

553 (27)

  NEMS <14

42(4)

40 (4)

82 (4)

  NEMS, missing data

62 (6)

40 (4)

102 (5)

Patients leading diagnosis in AEs questionnaire, n (%)

   

  >1 leading diagnosis

446 (42)

332 (34)

778 (38)

  Respiratory disorders

204 (19)

213 (22)

409 (20)

  Cardiovascular disorders

176 (16)

172 (18)

348 (17)

  Neurological disorders

77 (7)

66 (7)

143 (7)

  Postoperative

60 (6)

63 (6)

123 (6)

  Other

134 (13)

112 (11)

246 (12)

AE categories, n (%)

   

  Drug-related

506 (47)

478 (49)

984 (48)

  Indwelling lines, catheters and drains

135 (13)

110 (11)

245 (12)

  Communication and planning

107 (10)

104 (11)

213 (10)

  Airway

100 (9)

88 (9)

188 (9)

  Equipment

75 (7)

89 (9)

164 (8)

  Other procedures (bronchoscopy, EGD, electrical cardioversion…)

75 (7)

60 (6)

135 (7)

  Others (documentation, positioning…)

64 (6)

54 (6)

118 (6)

  1. Data are presented for the pre-implementation period (first 12 months), for the post-implementation period (last 12 months), and for the whole study period (24 months). AE, adverse event; EGD, esophagogastroduodenoscopy; NEMS, nine equivalents of nursing manpower use score; MD, medical doctor.